Author
Listed:
- Abdul Bari Hejran
(Department of Biology, Faculty of Education, Helmand University, Helmand, AFGHANISTAN; Department of Biotechnology, faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty 050040, KAZAKHSTAN)
- Atiqullah Sarwari
(Department of Biology, Faculty of Education, Helmand University, Helmand, AFGHANISTAN)
- Virendra Kumar Yadav
(Marwadi University Research Center, Department of Microbiology, Faculty of Sciences, Marwadi University, Rajkot-360003, Gujarat, India)
- Mohammad Hassan Hassand
(Department of Biology, Faculty of Education, Kandahar University, Kandahar, AFGHANISTAN)
- Parwiz Niazi
(Department of Biology, Faculty of Education, Kandahar University, Kandahar, AFGHANISTAN; Department of Plant Protection, Faculty of Agriculture, EGE University, İzmir, TURKEY)
Abstract
Antiviral chemotherapy, an indispensable tool in combating viral infections, faces numerous challenges that often undermine its overall effectiveness and application. This review critically examines the multifaceted issues associated with antiviral chemotherapy, drawing on comprehensive data from NCBI, PubMed, and other reputable academic sources. The primary purpose of this research is to analyze and evaluate key problems such as the development of drug resistance, narrow therapeutic windows, limited spectrum of activity, toxicity, high costs, viral latency, and the complexities inherent in combination therapy. These challenges necessitate a delicate and strategic balance in the development, regulation, and application of antiviral drugs. The research methodology included an exhaustive review of peer-reviewed articles and clinical studies sourced from PubMed and NCBI databases, focusing on ten critical challenges in antiviral chemotherapy. The findings underscore the persistent issue of drug resistance, particularly in RNA viruses like HIV and hepatitis C, which demand ongoing innovation in antiviral drug design and implementation. Additionally, the analysis reveals the significant risks posed by the narrow therapeutic index of many antiviral drugs, which often increases the likelihood of adverse effects, thus limiting their safe and effective use. The study also highlights the formidable challenges posed by viral latency and the limited efficacy of current therapies against emerging and re-emerging viral threats. This research significantly contributes to the understanding of the inherent limitations in existing antiviral therapies and underscores the pressing need for more effective, accessible, and safe treatments. The practical significance lies in offering insights that could guide future research, clinical practice, and policy decisions, ultimately improving global health outcomes in the fight against viral diseases.
Suggested Citation
Abdul Bari Hejran & Atiqullah Sarwari & Virendra Kumar Yadav & Mohammad Hassan Hassand & Parwiz Niazi, 2024.
"Analyzing and Critically Evaluating the Problems of Antiviral Chemotherapy,"
British Journal of Pharmacy and Pharmaceutical Sciences, Al-Kindi Center for Research and Development, vol. 1(1), pages 47-59, June.
Handle:
RePEc:alk:bjpps0:v:1:y:2024:i:1:id:7802
DOI: 10.32996/bjpps.2024.1.1.6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:alk:bjpps0:v:1:y:2024:i:1:id:7802. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Al-Kindi Center for Research and Development (email available below). General contact details of provider: https://al-kindipublisher.com/index.php/bjpps .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.